FREE

Section: Webinars Category: Wound Care

Evidence-Based Incorporation of Low-frequency Ultrasound into the Practice of Wound Care

Thomas Serena, MD

Thomas Serena, MD discusses the importance of biofilms in chronic wounds and how they impede wound healing. Dr Serena also reviews the mechanisms of action of low-frequency and how they impede wound healing as well as help implement technology to effectively treat bacterial biofilms in chronic wounds.

Goals and Objectives
  1. Review the importance of biofilms in chronic wounds and how they impede wound healing
  2. Review the mechanisms of action of low-frequency ultrasound in wound healing
  3. Compose a plan to implement technology to effectively treat bacterial biofilms in chronic wounds
  • Author
  • Thomas Serena, MD

    Vice President - American College of Hyperbaric Medicine
    Founder & Medical Director, Penn North Centers for Advanced Wound Care
    Erie, PA

  • System Requirements
  • To view Lectures online, the following specs are required:

    • PC Pentium-III class or better processor
    • 256MB minimum of RAM
    • Cable or DSL broadband Internet
    • Browsers must have javascript enabled. Most browsers have this feature enabled by default.
    • Adobe Acrobat Reader (Free) to print certificates
    • Supported Browsers:
      • Chrome
      • Firefox
      • IE 10+
      • Safari
      Supported Mobile OS:
      • Apple iOS 4.3+
      • Android 2.3+
      • Honeycomb 3.1+
      • Blackberry Playbook
  • Disclosure Information
  • It is the policy of PRESENT e-Learning Systems and it's accreditors to insure balance, independence, objectivity and scientific rigor in all its individually sponsored or jointly sponsored educational programs. All faculty participating in any PRESENT e-Learning Systems sponsored programs are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic. The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation. It is merely intended that any potential conflict should be identified openly so that the listeners may form their own judgments about the presentation with the full disclosure of the facts.

    ---

    Thomas Serena has disclosed to be a consultant/advisor for Smith and Nephew, MolecuLight, Organogenesis, Mego Aflec/lympha Press USA, Molnlycke Health Care, Rogers Sciences, Integra, RedDress, Cardiovascular Biotherapeutics and Tissue Therapeutics.